Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Long-Term Debt Repayments (2016 - 2023)

Merit Medical Systems' Long-Term Debt Repayments history spans 13 years, with the latest figure at $73.2 million for Q3 2023.

  • For Q3 2023, Long-Term Debt Repayments fell 1.18% year-over-year to $73.2 million; the TTM value through Sep 2023 reached $453.2 million, up 74.54%, while the annual FY2022 figure was $260.1 million, 25.72% up from the prior year.
  • Long-Term Debt Repayments for Q3 2023 was $73.2 million at Merit Medical Systems, down from $268.4 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $268.4 million in Q2 2023 and bottomed at $24.5 million in Q1 2020.
  • The 5-year median for Long-Term Debt Repayments is $54.1 million (2019), against an average of $64.1 million.
  • The largest annual shift saw Long-Term Debt Repayments crashed 63.67% in 2019 before it surged 400.18% in 2023.
  • A 5-year view of Long-Term Debt Repayments shows it stood at $52.7 million in 2019, then crashed by 45.53% to $28.7 million in 2020, then surged by 112.74% to $61.0 million in 2021, then rose by 0.83% to $61.6 million in 2022, then rose by 18.85% to $73.2 million in 2023.
  • Per Business Quant, the three most recent readings for MMSI's Long-Term Debt Repayments are $73.2 million (Q3 2023), $268.4 million (Q2 2023), and $50.1 million (Q1 2023).